↧
AstraZeneca raises bet on cancer immunotherapy with Immunocore deal
AstraZeneca raises bet on cancer immunotherapy with Immunocore deal Yahoo/Reuters
View ArticleDeals Of The Week: UCSF Catalyzes R&D Tech-Transfer Deals With Private Sector
Deals Of The Week: UCSF Catalyzes R&D Tech-Transfer Deals With Private Sector In Vivo Blog
View ArticleAstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints
AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints The Fly on the Wall
View Article